Glenmark adapalene 0.1 percent launch in the US highlights an established acne therapy and its relevance to India's evolving dermatology treatment landscape.
Zydus advances its specialty ambitions with the first generic Adempas launch in the U.S., expanding access to lower-cost pulmonary hypertension treatment.
Lupin Limited has launched Formoflo-G MDI, a fixed-dose triple-combination metered-dose inhaler for COPD treatment in India. The launch, announced on October 6, 2026, expands the company’s respiratory care portfolio and adds another...
Biodeal's 135 million-unit acquisition of Biological E’s sterile injectable facility highlights India’s intensifying CDMO capacity scramble.
Oral obesity drugs are gaining momentum as Novo Nordisk's USD 2.6 billion deal with Hengrui highlights the shift toward next-generation treatments.
The Pharma Manufacturing & Automation Excellence Awards 2026(PM&AE Awards 2026) celebrates the organizations, leaders, and professionals who are redefining pharmaceutical manufacturing through operational excellence, smart manufacturing
For years, the pharmaceutical industry has invested heavily in automation, digitisation and smart manufacturing technologies. Yet, despite these advancements, organisations continue to face familiar challenges
Sun Pharma Lerodalcibep deal with LIB Therapeutics gives the company access to a growing PCSK9 market, strengthening its cardiovascular portfolio and expanding its innovative medicines strategy.
This week’s GLP-1 battle intensifies as Novo slips, Roche climbs, and Lilly expands with major obesity and diabetes advances.
Regulatory Check Today shows the FDA backing two oral treatments while maintaining strict evidence standards for accelerated approval.
.jpg)
, CDSCO.jpg)